SCHEMBL24310518

SCHEMBL24310518

CSc1cc(-c2c(C)cccc2C)nc(NS(=O)(=O)c2cccc(NO)c2)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.40
▸ PKM P14618 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ PCTP Q9UKL6 1/20 0.38
▸ STARD10 Q9Y365 1/20 0.38
▸ GAA P10253 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ SRC P12931 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PDGFRB P09619 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ FNTA P49354 1/20 0.36
▸ FNTB P49356 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ CA1 P00915 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310519 0.85 TSHR (0.40) TSHRPKMLMNAPCTPSTARD10
SCHEMBL26807044 0.81 LMNA (0.56) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL24310735 0.79 PIK3CD (0.39) TSHRPKMGAASMN1; SMN2ALDH1A1
SCHEMBL26833740 0.74 KMT2A (0.47) TSHRLMNAHPGDSMN1; SMN2ALDH1A1
SCHEMBL29566636 0.73 GAA (0.35) TSHRLMNAGAASMN1; SMN2ALDH1A1
SCHEMBL26651236 0.73 GAA (0.35) TSHRLMNAGAASMN1; SMN2ALDH1A1
SCHEMBL26822143 0.72 CYTH2 (0.45) TSHRPKMPCTPSTARD10GAA
SCHEMBL24309265 0.71 MAPT (0.63) TSHRPKMLMNAGAAHPGD
SCHEMBL26849718 0.71 HTR6 (0.44) TSHRPKMLMNAGAASMN1; SMN2
SCHEMBL29567025 0.71 LMNA (0.54) LMNAALDH1A1KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback